Correlates of adherence to varenicline among HIV+ smokers

Nicotine and Tobacco Research

Volumn 17, Issue 8, 2015, Pages 968-974

  Shelley, Donna ^a   Tseng, Tuo Yen ^a   Gonzalez, Mirelis ^a   Krebs, Paul ^a   Wong, Selena ^a   Furberg, Robert ^b   Sherman, Scott ^a,c   Schoenthaler, Antoinette ^a   Urbina, Anthony ^d   Cleland, Charles M ^d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RTI INTERNATIONAL   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARENICLINE; NICOTINIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MIDDLE AGED; MOTIVATION; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT DURATION; UNITED STATES; CLINICAL TRIAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICATION COMPLIANCE; NEW YORK; PILOT STUDY; PROCEDURES;

FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEW YORK CITY; NICOTINIC AGONISTS; PILOT PROJECTS; SMOKING CESSATION; VARENICLINE;

EID: 84939482403     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv068     Document Type: Article

References (40)

1. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145(6), 397-406. doi:10.7326/0003-4819-145-6-200609190-00003.
2. Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of non adherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008;10(4), 731-736. doi:10.1080/14622200801908190.
3. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phonedelivered smoking cessation counseling for persons living with HIV/AIDS:3-month outcomes. Nicotine Tob Res. 2012;14(1), 106-110. doi:10.1093/ntr/ntr121.
4. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012;61(2), 208-215. doi:10.1097/QAI.0b013-3182645679.
5. Humfleet GL, Hall SM, Delucchi KL, Dilley JW. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res. 2013;15(8), 1436-1445. doi:10.1093/ntr/ntt005.
6. Stanton CA, Lloyd-Richardson EE, Papandonatos GD, de Dios MA, Niaura R. Mediators of the relationship between nicotine replacement therapy and smoking abstinence among people living with HIV/AIDS. AIDS Educ Prev. 2009;21(suppl 3), 65-80. doi:10.1521/aeap.2009.21.3śupp.65.
7. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction. 2009;104(11), 1891-1900. doi:10.111 1/j.1360-0443.2009.0262 3.x.
8. Fucito LM, Toll BA, Salovey P, O'Malley SS. Beliefs and attitudes about bupropion: Implications for medication adherence and smoking cessation treatment. Psychol Addict Behav. 2009;23(2), 373-379. doi:10.1037/a0015695.
9. Mooney ME, Sayre SL, Hokanson PS, Stotts AL, Schmitz JM. Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: a replication and extension study. Addict Behav. 2007;32(4), 875-880. doi:10.1016/j.addbeh.2006.06.022.
10. Cioe PA. Smoking cessation interventions in HIV-infected adults in North America: a literature review. J Addict Behav Ther Rehabil. 2013;2(3), 1000112. doi:10.4172/2324-9005.1000112.
11. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13(3), 545-554. doi:10.1007/s10461-007-9334-4.
12. Cui Q, Robinson L, Elston D, et al. Safety and Tolerability of Varenicline Tartrate (Champix/Chantix) for Smoking Cessation in HIV-Infected Subjects: A Pilot Open-Label Study. AIDS Patient Care. 2012;26(1), 12-19. doi:10.1089/apc.2011.0199.
13. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD:U.S. DIANE Publishing; 2008.
14. Catz SL, Jack LM, McClure JB, et al. Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 2011;5(5), 361-368. doi:10.1093/ntr/ntr003.
15. Nollen NL, Cox LS, Nazir N, et al. A pilot clinical trial of varenicline for smoking cessation in black smokers. Nicotine Tob Res. 2011;13(9), 868-873. doi:10.1093/ntr/ntr063.
16. Hays JT, Leischow SJ, Lawrence D, Lee TC. Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence. Nicotine Tob Res. 2010;12:574-581. doi:10.1093/ntr/ntq047.
17. Raupach T, Brown J, Herbec A, Brose L, West R. A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. Addiction. 2014;109:35-43. doi:10.1111/add.12319.
18. Nollen NL, Mayo MS, Ahluwalia JS, et al. Factors associated with discontinuation of bupropion and counseling among African American light smokers in a randomized clinical trial. Ann Behav Med. 2013;46(3), 336-348. doi:10.1007/s12160-013-9510-x.
19. Niaura R, Chander G, Hutton H, Stanton C. Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals. Current HIV/AIDS Rep. 2012;9:375-384. doi:10.1007/s11904-012-0138-4.
20. Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivationbehavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25:462-473. doi:10.1037/0278-6133.25.4.462.
21. Starace F, Massa A, Amico KR, Fisher JD. Adherence to antiretroviral therapy:an empirical test of the information-motivation-behavioral skills model. Health Psychol. 2006;25:153-162. doi:10.1037/0278-6133.25.2.153.
22. Skinner, HA. The drug abuse screening test. Addict Behav. 1982;7:363-371. doi:10.1016/0306-4603(82)90005-3.
23. Bush K, Kihlavan DR, McConell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Int Med. 1998;158(16), 1789-1795. doi:10.1001/archinte.158.16.1789.
24. Buchanan TA, Carla BJ, Cox LS, et al. Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report. Nicotine Tob Res. 2012;14:1083-1091. doi:10.1093/ntr/ntr333.
25. Shiffman S, Sweeney C, Ferguson S, Sembower MA, Citchell JG. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10 week randomized, doubleblind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clin Ther. 2008;30(10), 1852-1858. doi:10.1016/j. clinthera.2008.09.016.
26. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86:1119-1127. doi:10.1111/j.1360-0443.1991. tb01879.x.
27. Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exper Res. 2007;31:1208-1217. doi:10.1111/j.1530-0277.2007.00403.x.
28. Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in Criminal Justice and Detoxification Settings and in a Swedish Population Sample. Eur Addict Res. 2005;11:22-31. doi:10.1159/000081413.
29. Berg KM, Wilson IB, Li X, Arnsten JH. Comparison of antiretroviral adherence questions. AIDS Behav. 2012;16:461-468. doi:10.1007/s10461-010-9864-z.
30. The LifeWindows Project Team. The LifeWindows Information Motivation Behavioral Skills ART Adherence Questionnaire (LW-IMBAAQ). Center for Health, Intervention, and Prevention, University of Connecticut; 2006. www.chip.uconn.edu/chipweb/documents/Research/FLWIMBARTQuestionnaire.pdf. Accessed September 23, 2010.
31. Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med. 2008;31:453-462. doi:10.1007/s10865-008-9170-7.
32. Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIVASES). J Behav Med. 2007;30:359-370. doi:10.1007/s10865-007-9118-3.
33. Muthén LK, Muthén BO. Mplus User's Guide, Seventh Edition. Los Angeles, CA: Muthén & Muthén; 1998-2012.
34. Liberman JN, Lichtenfeld MJ, Galaznik A, et al. Adherence to varenicline and associated smoking cessation in a community-based patient setting. J Manag Care Pharm. 2013;19:125-131. www.amcp.org/JMCP/2013/March/16234/1033.html. Accessed May 13, 2014.
35. Simoni JM, Huh D, Wilson IB, et al. Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr. 2012;60(5), 466-472. doi:10.1097/QAI.0b013-31825db0bd.
36. Reynolds NR, Testa MA, Marc LG, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy:a multicenter, cross-sectional study. AIDS Behav. 2004;8:141-150. doi:10.1023/B:AIBE.0000030245.52406.bb.
37. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7:511-522. doi:10.1080/14622200500186064.
38. Mooney ME, Sayre SL, Hokanson PS, Sotts AL, Schmitz JM. Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: a replication and extension study. Addict Behav. 2007;32:875-880.
39. Okuyemi KS, Goldade K, Whembolua GL, et al. Motivational interviewing to enhance nicotine patch treatment for smoking cessation among homeless smokers: a randomized controlled trial. Addiction. 2013;108(6), 1136-1144. doi:10.1111/add.12140.
40. Osterberg L, Blaschke T. Adherence to medication. New Eng J Med. 2005;353(5), 487-497. doi:10.1056/NEJMra050100.